Table 1 Baseline characteristics of HIV-positive patients with CMVR at MTY Clinic, Myanmar, 2013–2017
Total (N = 53) | Local treatment (N = 21) | Systemic treatment (N = 32) | P value | |
|---|---|---|---|---|
Male sex, N (%) | 29 (55) | 10 (48) | 19 (59) | 0.576 |
Median age, years (IQR) | 37 (34–42) | 37 (34–42) | 38 (34–46) | 0.722 |
Year of CMV diagnoses, N (%) | < 0.001 | |||
2013 | 15 (28) | 15 (71) | 0 (0) | |
2014 | 14 (26) | 4 (19) | 10 (31) | |
2015 | 20 (38) | 2 (9.5) | 18 (56) | |
2016 | 4 (7.5) | 0 (0) | 4 (13) | |
Median (IQR) CD4 count, cells/μLa | 18 (10–44) | 31 (15–46) | 16 (7.8–41) | 0.103 |
Patient type, N (%) | 0.472 | |||
New | 31 (58) | 13 (62) | 18 (56) | |
Interrupted treatment | 3 (5.7) | 2 (9.5) | 1 (3.1) | |
On ART | 19 (36) | 6 (29) | 13 (41) | |
Median (IQR) Hb, g/dLb | 9.7 (9.1–11) | 10 (9.2–11) | 9.5 (8.1–10) | 0.133 |
Bilateral retinitis, N (%)c | 20 (38) | 10 (48) | 10 (31) | 0.218 |